U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895238) titled 'A Study of Perioperative Adebrelimab Plus Chemotherapy Versus Adjuvant Therapy in Patients With Resectable NSCLC' on Oct. 19.
Brief Summary: This is a randomized, multicenter, phase III clinical study to compare the efficacy and safety of perioperative treatment with adebrelimab plus platinum-based chemotherapy versus adebrelimab adjuvant therapy in patients with resectable stage II-IIIB non-small-cell lung cancer(NSCLC).
Study Start Date: Oct. 31
Study Type: INTERVENTIONAL
Condition:
Non-small Cell Lung Cancer (NSCLC)
Intervention:
DRUG: Adebrelimab (SHR-1316) + chemotherapy
3 cycles of adebrelimab 1200 mg plus platinum-cont...